Evidence map›Paper›PMID 35635137›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2022

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs.

Andrea Angeli, Marta Ferraroni, Fabrizio Carta, Cécile Häberli, Jennifer Keiser, Gabriele Costantino, Claudiu T Supuran

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andrea AngeliNEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Florence, Italy.ORCID 0000-0002-1470-7192
Marta FerraroniDepartment of Food and Drug, University of Parma, Parco Area delle Scienze, Parma, Italy.
Fabrizio CartaNEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Florence, Italy.
Cécile HäberliDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-1282-8070
Jennifer KeiserDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0003-0290-3521
Gabriele CostantinoDipartimento di Chimica "Ugo Schiff", University of Florence, Florence, Italy.
Claudiu T SupuranNEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Florence, Italy.ORCID 0000-0003-4262-0323
Istituto Nazionale di Fisica Nucleare, Sezione di Firenze · ITSwiss Tropical and Public Health Institute · CHUniversity of Florence · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The almost empty armamentarium to treat schistosomiasis, a neglected parasitic disorder caused by trematode flatworms of the genus

Indexed as

Carbonic AnhydrasesSchistosomicidesAnimalsHumansPraziquantelSchistosoma mansoniSulfanilamideSulfonamidesCarbonic AnhydrasesPraziquantelSchistosomicidesSulfanilamideSulfonamidesCarbonic anhydrasemetalloenzymespraziquantelSchistosoma mansonischistosomiasissulphonamide

Identifiers

PMID35635137
PMCPMC9154761
OpenAlexW4281630250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.